Reply to my email!11 Apr 2024 12:58
Just had a reply back from Consilium!
Thanks for your recent enquiry. You can expect announcements from the Company when substantive milestones are reached, and as per the financial calendar, with full year results for 2023 due to be reported in Q2.
We are planning to progress our next steps, based on insights from non-interventional studies, to assess SNG001 in target patient groups with the highest needs.
Make what you will of this but I had asked why the SP had increased so much over the last few days! They havent said its for no reason! So i expect something is happening in the back group!